ClinVar Genomic variation as it relates to human health
NM_001927.4(DES):c.1048C>T (p.Arg350Trp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Pathogenic(1); Likely pathogenic(1); Uncertain significance(5)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001927.4(DES):c.1048C>T (p.Arg350Trp)
Variation ID: 44244 Accession: VCV000044244.20
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q35 2: 219421364 (GRCh38) [ NCBI UCSC ] 2: 220286086 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 19, 2013 Oct 8, 2024 Feb 5, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001927.4:c.1048C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001918.3:p.Arg350Trp missense NC_000002.12:g.219421364C>T NC_000002.11:g.220286086C>T NG_008043.1:g.7988C>T LRG_380:g.7988C>T LRG_380t1:c.1048C>T - Protein change
- R350W
- Other names
- -
- Canonical SPDI
- NC_000002.12:219421363:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00001
Exome Aggregation Consortium (ExAC) 0.00002
The Genome Aggregation Database (gnomAD), exomes 0.00002
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00008
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
DES | - | - |
GRCh38 GRCh37 |
1062 | 1108 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Sep 5, 2012 | RCV000037224.5 | |
Uncertain significance (3) |
criteria provided, multiple submitters, no conflicts
|
Jul 13, 2022 | RCV000056766.5 | |
Likely pathogenic (2) |
criteria provided, single submitter
|
Feb 5, 2024 | RCV000157164.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Dec 25, 2023 | RCV001039932.6 | |
Pathogenic (1) |
no assertion criteria provided
|
Mar 13, 2007 | RCV001250885.2 | |
Uncertain significance (1) |
criteria provided, single submitter
|
May 9, 2023 | RCV003486560.1 | |
DES-related disorder
|
Uncertain significance (1) |
no assertion criteria provided
|
Jan 24, 2024 | RCV003398603.6 |
Uncertain significance (1) |
criteria provided, single submitter
|
Mar 4, 2022 | RCV003298065.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Sep 05, 2012)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: not provided
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV000060881.5
First in ClinVar: May 03, 2013 Last updated: Jan 31, 2015 |
Comment:
Variant classified as Uncertain Significance - Favor Pathogenic. The Arg350Trp i n DES gene has been reported in 1 55 year old individual with DCM … (more)
Variant classified as Uncertain Significance - Favor Pathogenic. The Arg350Trp i n DES gene has been reported in 1 55 year old individual with DCM (Taylor 2007). This variant has also been identified in 1/8600 European American chromosomes f rom a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wash ington.edu/EVS; dbSNP rs62636492). This could represent a presymptomatic individ ual and the overall low population frequency supports pathogenicity. In vitro st udies showed disruption of the desmin filament assembly, although in vitro assay s do not always accurately reflect biological function (Taylor 2007). Arginine ( Arg) at position 350 is highly conserved evolution and computational analyses (b iochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) suggest that t his variant may impact the protein (the accuracy of these tools is unknown). Fin ally, another variant at this position (Arg350Pro) has been reported as a pathog enic variant in individuals with conduction system disease, and cardiac and skel etal myopathy (Bar 2005, Walter 2007, Levin 2010). In summary, the available dat a supports that the Arg350Trp variant may be pathogenic, though additional studi es are needed to fully assess its clinical significance. (less)
Number of individuals with the variant: 1
|
|
Uncertain significance
(Jul 13, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002549512.2
First in ClinVar: Jul 23, 2022 Last updated: Mar 04, 2023 |
Comment:
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies suggest that desmin protein harboring p.(R350W) results … (more)
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies suggest that desmin protein harboring p.(R350W) results in disruption of desmin filament assembly (Taylor et al., 2007); This variant is associated with the following publications: (PMID: 17439987, 27896284, 29247119, 23299917, 17325244, 20474083, 20448486, 15800015, 22337857, 29926427, 31514951, 28416588, 33500567, 31983221, 32150461, 29386531) (less)
|
|
Uncertain significance
(May 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiomyopathy
Affected status: unknown
Allele origin:
germline
|
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Accession: SCV004240479.1
First in ClinVar: Feb 04, 2024 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Dec 25, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Desmin-related myofibrillar myopathy
Desmin-related myofibrillar myopathy
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001203482.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 350 of the DES protein … (more)
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 350 of the DES protein (p.Arg350Trp). This variant is present in population databases (rs62636492, gnomAD 0.007%). This missense change has been observed in individuals with dilated cardiomyopathy (PMID: 17325244, 29247119, 29386531; Invitae). ClinVar contains an entry for this variant (Variation ID: 44244). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DES protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects DES function (PMID: 17325244). This variant disrupts the p.Arg350 amino acid residue in DES. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15800015, 17439987, 20448486, 25394388, 27393313). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Uncertain significance
(Nov 04, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003829004.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Likely pathogenic
(Feb 05, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Primary dilated cardiomyopathy
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Molecular Genetics, Royal Melbourne Hospital
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV004812277.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
Comment:
This sequence change in DES is predicted to replace arginine with tryptophan at codon 350, p.(Arg350Trp). The arginine residue is highly conserved (100 vertebrates, UCSC), … (more)
This sequence change in DES is predicted to replace arginine with tryptophan at codon 350, p.(Arg350Trp). The arginine residue is highly conserved (100 vertebrates, UCSC), and is located in the intermediate filament (IF) rod domain. There is a large physicochemical difference between arginine and tryptophan. The highest population minor allele frequency in the population database gnomAD v4.0 is 0.002% (25/1,180,008 alleles) in the European (non-Finnish) population, which is consistent with dilated cardiomyopathy. This variant has been reported in at least seven unrelated individuals with dilated cardiomyopathy (PMID: 17325244, 28416588, 29386531, 31983221, 33823640; ClinVar: SCV000206887.1, SCV001203482.4). An in vitro functional assay with limited validation in neonatal rat myocytes showed that the formation of desmin filaments was affected in the presence of the variant indicating that it impacts protein function (PMID: 17325244). Computational evidence predicts a deleterious effect for the missense substitution (REVEL =0.853). Another missense variant c.1049G>C, p.(Arg350Pro) in the same codon has been classified as pathogenic for DES-related myofibrillar myopathy (ClinVar ID: 16835; PMID: 25394388, 15800015). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PM2_Supporting, PM5, PP3, PS3_Supporting, PS4_Moderate (less)
|
|
Uncertain significance
(Mar 04, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV003995335.2
First in ClinVar: Jul 08, 2023 Last updated: May 01, 2024 |
Comment:
The c.1048C>T (p.R350W) alteration is located in exon 6 (coding exon 6) of the DES gene. This alteration results from a C to T substitution … (more)
The c.1048C>T (p.R350W) alteration is located in exon 6 (coding exon 6) of the DES gene. This alteration results from a C to T substitution at nucleotide position 1048, causing the arginine (R) at amino acid position 350 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. (less)
|
|
Likely pathogenic
(Sep 29, 2014)
|
no assertion criteria provided
Method: clinical testing
|
Primary dilated cardiomyopathy
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV000206887.1
First in ClinVar: Feb 06, 2015 Last updated: Feb 06, 2015 |
Number of individuals with the variant: 1
|
|
Pathogenic
(Mar 13, 2007)
|
no assertion criteria provided
Method: literature only
|
CARDIOMYOPATHY, DILATED, 1I
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV001426378.2
First in ClinVar: Aug 03, 2020 Last updated: Sep 01, 2020 |
Comment on evidence:
In a man who was diagnosed with dilated cardiomyopathy (CMD1I; 604765) at age 55 years, Taylor et al. (2007) identified heterozygosity for a c.1134C-T transition … (more)
In a man who was diagnosed with dilated cardiomyopathy (CMD1I; 604765) at age 55 years, Taylor et al. (2007) identified heterozygosity for a c.1134C-T transition in the DES gene, resulting in an arg350-to-trp (R350W) substitution at a residue within the conserved alpha-helical coil of the 2B rod domain. DNA from family members was unavailable for analysis, but the mutation was not found in 300 control chromosomes. The proband, who was negative for mutation in 6 known CMD-associated genes, had no overt skeletal muscle involvement, and creatine kinase level was normal. Immunofluorescence microscopy of transfected SW13 cells, human coronary artery smooth muscle cells, and neonatal rat cardiac myocytes expressing the R350W mutation revealed severe disruption of the normal desmin cytoskeletal architecture in the majority of transfected cells, with clumping and aggregation of antibody-positive staining cytoplasmic protein. The mutation demonstrated a dominant phenotype in the human coronary artery smooth muscle cell lines, in which constitutively expressed desmin was unable to compensate for the presence of the R350W mutant. (less)
|
|
Uncertain significance
(Jan 24, 2024)
|
no assertion criteria provided
Method: clinical testing
|
DES-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004103509.3
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The DES c.1048C>T variant is predicted to result in the amino acid substitution p.Arg350Trp. This variant was reported in individuals with dilated cardiomyopathy, hypertrophic cardiomyopathy, … (more)
The DES c.1048C>T variant is predicted to result in the amino acid substitution p.Arg350Trp. This variant was reported in individuals with dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular noncompaction, or sudden unexplained deaths (Taylor et al. 2007. PubMed ID: 17325244; Table S3, Lin et al. 2017. PubMed ID: 29247119; Online Table 1, Gigli et al. 2019. PubMed ID: 31514951; Table S1, Hoss et al. 2020. PubMed ID: 32150461; Table S2, Mazzarotto et al. 2021. PubMed ID: 33500567). Functional studies suggested that this variant could disrupt the intracytoplasmic localization (Taylor et al. 2007. PubMed ID: 17325244). However, this variant was also documented in the general population (Andreasen et al. 2013. PubMed ID: 23299917; Table S1, Nouhravesh et al. 2016. PubMed ID: 27896284). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD and has conflicting interpretations of pathogenicity in ClinVar ranging from uncertain significance to pathogenic (http://www.ncbi.nlm.nih.gov/clinvar/variation/44244). A different nucleotide substitution affecting the same amino acid (p.Arg350Pro) has been reported to be causative for DES-associated disorders (Bar et al. 2005. PubMed ID: 15800015; Walter et al. 2007. PubMed ID: 17439987). Although we suspect that the c.1048C>T (p.Arg350Trp) variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
Epithelial Biology; Institute of Medical Biology, Singapore
Accession: SCV000087879.1
First in ClinVar: Oct 19, 2013 Last updated: Oct 19, 2013 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Heterozygous desmin gene (DES) mutation contributes to familial dilated cardiomyopathy. | Huang YS | The Journal of international medical research | 2021 | PMID: 33823640 |
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy. | Mazzarotto F | Circulation | 2020 | PMID: 31983221 |
Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. | Tobita T | Scientific reports | 2018 | PMID: 29386531 |
Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths. | Lin Y | Circulation. Cardiovascular genetics | 2017 | PMID: 29247119 |
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. | Dal Ferro M | Heart (British Cardiac Society) | 2017 | PMID: 28416588 |
Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue. | Winter L | Acta neuropathologica | 2016 | PMID: 27393313 |
The toxic effect of R350P mutant desmin in striated muscle of man and mouse. | Clemen CS | Acta neuropathologica | 2015 | PMID: 25394388 |
Divergent molecular effects of desmin mutations on protein assembly in myofibrillar myopathy. | Levin J | Journal of neuropathology and experimental neurology | 2010 | PMID: 20448486 |
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. | Walter MC | Brain : a journal of neurology | 2007 | PMID: 17439987 |
Prevalence of desmin mutations in dilated cardiomyopathy. | Taylor MR | Circulation | 2007 | PMID: 17325244 |
Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. | Bär H | Human molecular genetics | 2005 | PMID: 15800015 |
click to load more click to collapse |
Text-mined citations for rs62636492 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.